MML Investors Services
AUPH icon

MML Investors Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

MML Investors Services’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Sell
16,701
-4,940
-23% -$78.9K ﹤0.01% 2866
2026
Q1 		$321K Buy
21,641
+5,998
+38% +$87.7K ﹤0.01% 2516
2025
Q4 		$250K Buy
15,643
+1,765
+13% +$25K ﹤0.01% 2748
2025
Q3 		$153K Sell
13,878
-1,428
-9% -$15.6K ﹤0.01% 2790
2025
Q2 		$130K Sell
15,306
-126
-0.8% -$1.01K ﹤0.01% 2723
2025
Q1 		$124K Buy
+15,432
New +$125K ﹤0.01% 2610

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MML Investors Services's AUPH Position: Q2 2026 in Review

MML Investors Services reduced its Aurinia Pharmaceuticals (AUPH) stake by 23% in Q2 2026, selling an estimated $78.9K and leaving 16,701 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

MML Investors Services first reported a position in AUPH in Q1 2025 and has held it in 6 quarters since. The position peaked at $321K in Q1 2026. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • MML Investors Services held 16,701 shares of Aurinia Pharmaceuticals worth $283K as of Q2 2026.
  • MML Investors Services sold 4,940 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $78.9K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2866 holding.
  • MML Investors Services first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • MML Investors Services's Aurinia Pharmaceuticals position peaked at $321K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.